THE INFLUENCE OF INFORMATION ON DRUG-RESISTANCE ON PROTOCOL DESIGN - THE HENRY-KAPLAN-MEMORIAL-LECTURE, INTERNATIONAL-CONFERENCE ON MALIGNANT-LYMPHOMAS, 6-9 JUNE 1990, LUGANO, SWITZERLAND

被引:27
作者
DEVITA, VT
机构
[1] MEmorial Sloan-Kettering Cancer Center, New York, N.Y.
关键词
D O I
10.1093/oxfordjournals.annonc.a057892
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:93 / 106
页数:14
相关论文
共 90 条
[71]  
POPKIN J, 1985, P AN M AM SOC CLIN, V4, P149
[72]  
ROBEYCAFFERTY SS, 1990, AM J CLIN PATHOL, V93, P1
[73]  
Ross W E, 1988, Important Adv Oncol, P65
[74]  
SALMON SE, 1990, ADJUVANT THERAPY CAN, V6, P26
[75]   P-GLYCOPROTEIN EXPRESSION IN TREATED AND UNTREATED HUMAN-BREAST CANCER [J].
SCHNEIDER, J ;
BAK, M ;
EFFERTH, T ;
KAUFMANN, M ;
MATTERN, J ;
VOLM, M .
BRITISH JOURNAL OF CANCER, 1989, 60 (06) :815-818
[76]  
SHICH C, 1989, P AM ASSOC CANC RES, V30, P521
[77]  
SIMPSONHERREN L, 1976, CANCER TREAT REP, V60, P1749
[78]  
SKIPPER HE, 1986, CANCER TREAT REP, V70, P3
[79]  
SKIPPER HE, 1964, CANCER CHEMOTH REP, P3
[80]  
SKIPPER HE, IN PRESS IMPORTANT A